Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Peter Marks
Pharma
FDA's Peter Marks talks gene therapy pricing, patient follow-ups
After Orchard's gene therapy for a rare genetic disease was approved in March, Peter Marks received a simple email from Commissioner Robert Califf.
Annalee Armstrong
May 8, 2024 10:55am
FDA's Peter Marks shares more on CAR-T secondary cancer probe
Jan 25, 2024 10:42am
FDA's Marks went against reviewers' call on Sarepta's Elevidys
Jun 26, 2023 11:35am
FDA advisors vote to standardize COVID vaccines as bivalent
Jan 27, 2023 10:51am
FDA ups nod for GSK's Boostrix to protect babies from pertussis
Oct 10, 2022 10:08am
FDA limits the use of the J&J vax because of blood clot threat
May 6, 2022 9:12am
